Rajesh Power wins turnkey contract for 11KV MVCC project under KSY Scheme by PGVCL
By Aman Shukla Published on June 2, 2025, 10:48 IST
Rajesh Power Services has been declared the successful L1 bidder for a turnkey contract awarded by Paschim Gujarat Vij Company Ltd (PGVCL). The project involves the supply, installation, testing, and commissioning of 11KV Medium Voltage Covered Conductor (MVCC) under the Kisan Suryoday Yojana (KSY) scheme.
The scope of work will be carried out across selected areas under PGVCL's jurisdiction in Gujarat. The MVCC project is part of the KSY initiative, which aims to strengthen rural power infrastructure to support agricultural and domestic electricity needs.
In the excaghe filing, the Rajesh Power shared, 'The company has received a Lowest bid confirmation at the L1 Stage, being declared as the Successful Bidder for the Turnkey Contract for Supply, Installation, Testing and Commissioning of 11KV Medium Voltage Covered Conductor (MVCC) under KSY Scheme for Paschim Gujarat Vij Company Ltd (PGVCL).'
As the L1 bidder, Rajesh Power Services will be responsible for executing the project on a turnkey basis, ensuring compliance with PGVCL standards and timelines.
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
6 hours ago
- Business Upturn
Ashok Leyland secures Rs 183.80 crore order for 543 BSVI diesel buses from Tamil Nadu State Transport Corporation
Ashok Leyland has secured a significant order from the Tamil Nadu State Transport Corporation for the supply of 543 BSVI diesel chassis and fully built buses. This contract, valued at approximately ₹183.80 crores, is set to be executed between June 2025 and December 2025. Awarded through the standard tendering process, the order follows prudent business norms and does not involve any adverse terms or conditions. This is a domestic contract, both in terms of the awarding authority and the supply destination. The Tamil Nadu State Transport Corporation, a domestic entity, has chosen Ashok Leyland to fulfill this large-scale transportation order. It's important to note that neither Ashok Leyland's promoters nor their group companies have any financial or business interest in the awarding entity. The contract underscores Ashok Leyland's strong foothold in India's commercial vehicle sector and reflects growing demand for BSVI-compliant public transportation solutions across the country. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
8 hours ago
- Business Upturn
Is Peacemaker season 2 releasing in June 2025? Everything we know so far
By Aman Shukla Published on June 3, 2025, 19:00 IST Last updated June 3, 2025, 12:15 IST Fans of the hit DC series Peacemaker have been eagerly awaiting news about Season 2 since the first season's explosive debut in January 2022. Created by James Gunn and starring John Cena as the chaotic, peace-obsessed antihero Christopher Smith, the show became a standout success for HBO Max. With speculation swirling about its release date, one question persists: Is Peacemaker Season 2 releasing in June 2025? Here's everything we know so far. Is Peacemaker Season 2 Releasing in June 2025? No, Peacemaker Season 2 is not releasing in June 2025. According to official announcements from DC Studios and showrunner James Gunn, the second season is scheduled to premiere on August 21, 2025, on Max. Gunn confirmed this date via social media posts on April 7, 2025, stating, 'Counting the days until Peace on Earth. I just finished the DI & Mix on the Season Premiere yesterday and wow it's one of my favorite things ever. DC Studios' #Peacemaker Season 2 coming soon only on @StreamOnMax August 21.' This release follows the theatrical debut of Gunn's Superman film on July 11, 2025, aligning with the DC Universe timeline. Background on Peacemaker Peacemaker originated as a spin-off from the 2021 film The Suicide Squad , where John Cena's character, a jingoistic mercenary willing to kill for peace, stole the spotlight. The first season, an eight-episode run, followed Peacemaker's mission with Task Force X to stop an alien invasion known as Project Butterflies, blending dark humor, action, and surprising depth. Its success—culminating in a record-breaking finale viewership for Max in February 2022—prompted a swift renewal for Season 2. Where to Watch Peacemaker Season 2 will stream exclusively on Max in the US, starting August 21, 2025. Internationally, availability varies—expect it on JioHotstar in India, as noted by The New Indian Express. Season 1 is currently available on Max for a refresher. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
11 hours ago
- Business Upturn
Zydus secures licensing rights for next-gen immuno-oncology platforms from US-based Agenus
Zydus Lifesciences Limited, including its subsidiaries and affiliates ('Zydus'), has entered into an agreement with Agenus Inc. (NASDAQ: AGEN) to acquire the commercial rights for its investigational Botensilimab (BOT) and Balstilimab (BAL), combination therapy. Agenus is a clinical-stage immuno-oncology company focused on developing immune therapies for cancer treatment. The BOT/BAL combination is an immunotherapy currently in advanced clinical trials. It has shown clinical activity in studies involving over 1,200 patients with nine different types of cancer, in both late-stage and neoadjuvant treatment settings. Under the agreement, Zydus will handle clinical development and regulatory approvals for BOT/BAL in India and Sri Lanka. Upon successful approval and commercialization, Zydus will pay Agenus a 5% royalty on net sales. Zydus will also work on expanding the use of BOT/BAL beyond its initial indications to other areas with unmet medical needs and earlier treatment stages, including neoadjuvant therapy. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
